Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.74% | 178.19 | 0.7% | $1350.94m | |
| MRK | Merck & Co., Inc. | 0.21% | 92.61 | 0.7% | $1211.55m | |
| PFE | Pfizer Inc. | -1.20% | 51.68 | 0.9% | $1096.02m | |
| LLY | Eli Lilly & Co. | 0.74% | 327.13 | 1.1% | $1026.00m | |
| BMY | Bristol-Myers Squibb Co. | -1.13% | 75.97 | 1.0% | $991.64m | |
| ABBV | AbbVie, Inc. | 0.03% | 153.85 | 1.9% | $959.73m | |
| AZN | AstraZeneca Plc | -0.67% | 65.51 | 1.0% | $470.96m | |
| SGEN | Seagen Inc. | -1.85% | 176.77 | 5.7% | $326.06m | |
| GSK | GSK Plc | -1.01% | 43.31 | 0.2% | $272.45m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.05% | 75.15 | 0.0% | $199.28m | |
| HZNP | Horizon Therapeutics Plc | 2.38% | 82.76 | 5.4% | $174.09m | |
| NVS | Novartis AG | -0.11% | 84.27 | 0.2% | $172.25m | |
| MRTX | Mirati Therapeutics, Inc. | 1.10% | 71.96 | 1.6% | $150.81m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 1.67% | 150.73 | 8.1% | $150.31m | |
| NVO | Novo Nordisk A/S | -0.40% | 111.19 | 0.1% | $148.30m |
Company Profile
F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom.